July 28, 2011
AstraZeneca Pharmaceuticals LP has resolved nearly all suits accusing its blockbuster schizophrenia and bipolar disorder drug Seroquel of increasing the risk of diabetes, settling many claims brought in Florida multidistrict litigation but still facing holdouts in California courts, the company said Thursday.